Latest QIAGEN N.V. Stories
HILDEN, Germany, and MANCHESTER, England, November 11, 2014 /PRNewswire/ -- - Master collaboration agreement is a framework for developing and
VENLO, The Netherlands, October 29, 2014 /PRNewswire/ -- - Achieved Q3 2014 targets: Adjusted net sales of $336.8 million (+4% CER); adjusted operating
HILDEN, Germany and TOKYO, October 28, 2014 /PRNewswire/ -- - First two programs aim to create tests to aid in cancer treatment with Astellas compounds
HILDEN, Germany and BARCELONA, Spain, October 28, 2014 /PRNewswire/ -- - New WHO guidelines launched for prevention include screening and treating
SAN DIEGO and HILDEN, Germany, October 17, 2014 /PRNewswire/ -- - Translational research in cancer and other diseases will benefit from new capabilities
VENLO, The Netherlands, October 10, 2014 /PRNewswire/ -- QIAGEN N.V.
ReportsnReports.com offers "Microbial Identification Market Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic) Application (Pharmaceutical, Diagnostic, Environmental, Food
VENLO, the Netherlands, July 29, 2014 /PRNewswire/ -- - Achieved Q2 2014 targets: Adjusted net sales of $331.2 million (+4% CER); adjusted operating
HILDEN, Germany and LONDON, July 28, 2014 /PRNewswire/ -- - Collaboration aims to create and commercialize companion diagnostic using genomic data
HILDEN, Germany, and MARSEILLE, France, July 24, 2014 /PRNewswire/ -- - Exclusive global license from University of Tokyo enables development of
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.